☰

Jayanth Panyam, Ph.D.

Affiliations: 
2003 University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacy, Biomedical Engineering
Google:
"Jayanth Panyam"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Vinod Labhasetwar grad student 2003 University of Nebraska Medical Center
 (Biodegradable nanoparticles: Formulation, cellular mechanism and application for restenosis.)

Children

Sign in to add trainee
Zekun Shao grad student 2014- UMN
Ameya R. Kirtane grad student 2010-2015 UMN
Yafan Su grad student 2016-2018 UMN

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen CL, Hernandez JC, Uthaya Kumar DB, et al. (2023) Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206812
Prabha S, Merali C, Sehgal D, et al. (2023) Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing. Materials Today. Bio. 19: 100567
Bhatnagar S, Revuri V, Shah M, et al. (2022) Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers. 14
Oseni BA, Azubuike CP, Okubanjo OO, et al. (2021) Encapsulation of Andrographolide in poly(lactide-co-glycolide) Nanoparticles: Formulation Optimization and Efficacy Studies. Frontiers in Bioengineering and Biotechnology. 9: 639409
Cao J, Bhatnagar S, Wang J, et al. (2020) Cancer stem cells and strategies for targeted drug delivery. Drug Delivery and Translational Research
Kim H, Khanna V, Kucaba TA, et al. (2020) TLR7/8 Agonist Loaded Nanoparticles Augment NK Cell-mediated Antibody-based Cancer Immunotherapy. Molecular Pharmaceutics
Ganaie AA, Siddique HR, Sheikh IA, et al. (2020) A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems. Molecular Carcinogenesis
Kalscheuer S, Khanna V, Kim H, et al. (2019) Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer. Scientific Reports. 9: 12492
Khanna V, Kalscheuer S, Kirtane A, et al. (2019) Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future Drug Discovery. 1: FDD8
Liu G, Khanna V, Kirtane A, et al. (2019) Chemopreventive efficacy of oral curcumin: a prodrug hypothesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900166R
See more...